Cargando…
Cell-of-origin of diffuse large B-cell lymphomas determined by the Lymph2Cx assay: better prognostic indicator than Hans algorithm
Diffuse large B-cell lymphomas (DLBCLs) are clinically heterogeneous and need a biomarker that can predict the outcome of treatments accurately. To assess the prognostic significance of the cell-of-origin type for DLBCLs, we applied the Lymph2Cx assay using a NanoString gene expression platform on f...
Autores principales: | Yoon, Nara, Ahn, Soomin, Yoo, Hae Yong, Kim, Suk Jin, Kim, Won Seog, Ko, Young Hyeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400642/ https://www.ncbi.nlm.nih.gov/pubmed/28423544 http://dx.doi.org/10.18632/oncotarget.15782 |
Ejemplares similares
-
Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas
por: Schrader, Anne M. R., et al.
Publicado: (2022) -
Whole-exome and transcriptome sequencing of refractory diffuse large B-cell lymphoma
por: Park, Ha Young, et al.
Publicado: (2016) -
Clonal relationships in recurrent B-cell lymphomas
por: Lee, Seung Eun, et al.
Publicado: (2016) -
PB2380: DEVELOPING GENOMIC TESTS THAT GUIDE LARGE B-CELL LYMPHOMA DIAGNOSIS AND TREATMENT: LYMPH2CX AND LYMPH3CX ASSAYS
por: Robetorye, Ryan S., et al.
Publicado: (2023) -
Better than Membranes at the Origin of Life?
por: Hansma, Helen Greenwood
Publicado: (2017)